The value in evidence-based medicine is clear – the methods to gather and sort evidence-based information have been made available, and the next step is the practical application of this information to communication strategies. Bridging the gap between product development and commercialization when communicating with customers and stakeholders will be a key differential in product success in the future. Medical affairs, product development, and commercialization must create a new alliance to determine how to best reach payers, prescribers, and new customers – while retaining current customers – by demonstrating value throughout the product lifecycle with an emphasis on reducing risk.

Top Reasons to Attend

• Hear from top pharmaceutical executives about cross-functional evidence-based communication strategies
• Explore new technologies for communicating evidence-based information to key stakeholders and customers
• Address the concerns and demands of your customers and stakeholders – payors and ACOs – in the context of which your product is reimbursed
• Learn how to develop a product lifecycle communication plan
• Position new and mature products to fit the continuum of care and reduce risk for physicians, payers, and patients